Recruiting Hereditary Angioedema Studies in Phoenix
About Hereditary Angioedema Clinical Trials in Phoenix
Hereditary angioedema (HAE) is a rare genetic condition causing recurrent episodes of severe swelling in various body parts. It is caused by deficiency or dysfunction of C1 inhibitor protein. Treatment includes on-demand therapy for attacks and prophylactic medications to prevent episodes.
There are currently 2 hereditary angioedema clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 290 participants. Research is being sponsored by CSL Behring, Sanofi. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hereditary Angioedema Clinical Trials in Phoenix — FAQ
Are there hereditary angioedema clinical trials in Phoenix?
Yes, there are 2 hereditary angioedema clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Phoenix?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.
Are clinical trials in Phoenix free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.
What hereditary angioedema treatments are being tested?
The 2 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for hereditary angioedema.
Data updated August 28, 2026 from ClinicalTrials.gov